According to scientists from Israel, a cure for cancer is just a year away.

Dan Aridor, from Accelerated Evolution Biotechnologies Ltd. (founded in 2000), said “Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market. Our solution will be both generic and personal.”1

(Please watch the video below.)

If true, that would make cancer- currently the second leading cause of death worldwide- a manageable disease. Not the disease everyone currently fears.

RELATED STORY:

Accelerated Evolution Biotechnologies CEO Dr. Ilan Morad called the treatment MuTaTo (multi-target toxin), a kind of cancer antibiotic explaining that the new treatment “involves using several ‘cancer-targeting peptides for each cancer cell at the same time combined with a strong peptide toxin that would kill cancer cells specifically.'”2

This potential cancer-drug is based on SoAP technology:

“It involves the introduction of DNA coding for a protein, such as an antibody, into a bacteriophage – a virus that infects bacteria. That protein is then displayed on the surface of the phage. Researchers can use these protein-displaying phages to screen for interactions with other proteins, DNA sequences and small molecules.”3

The reason they made this discovery is because they wanted to (and eventually did) figure out why other cancer-killing drugs and treatments didn’t work or would eventually fail. Turns out most anti-cancer drugs attack a specific target on or in the cancer cell and “inhibiting the target usually affects a physiological pathway that promotes cancer. Mutations in the targets – or downstream in their physiological pathways – could make the targets not relevant to the cancer nature of the cell, and hence the drug attacking it is rendered ineffective.”4 So, what MuTaTo does is use a combo of several cancer-targeting peptides for each cancer cell at the same time and combined with a strong peptide toxin to kill cancer cells specifically. “By using at least three targeting peptides on the same structure with a strong toxin”5 the treatment isn’t “affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer.”6

RELATED STORY:

To read more about what the team in Israel is doing, click here.

According to Aridor, the team’s results are consistent and repeatable.

We will keep you updated.

 

SOURCE:

  1. The Jerulasem Post
  2. Fox News 4
  3. The Jerulasem Post
  4. The Jerulasem Post
  5. The Jerulasem Post
  6. The Jerulasem Post